Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidates.
Sorce G, Flammia RS, Hoeh B, Chierigo F, Hohenhorst L, Panunzio A, Stabile A, Gandaglia G, Tian Z, Tilki D, Terrone C, Gallucci M, Chun FKH, Antonelli A, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI.
Sorce G, et al. Among authors: panunzio a.
Prostate. 2022 Jun;82(10):1040-1050. doi: 10.1002/pros.24349. Epub 2022 Apr 1.
Prostate. 2022.
PMID: 35365851
Free PMC article.